Patents - Global Data - Dimensions
LONG-ACTING PTH COMPOUND TREATMENTS
Applicants:
- Ascendis Pharma Bone Diseases AS [NORA names: Ascendis Pharma; Private Research]
Abstract
The present invention relates to a long-acting PTH compound for use in the reduction of bone mineral density (BMD) in a patient having an increased BMD and to a particular dosage regimen of such long-acting PTH compound and other related aspects.
Patent Family Records (5)
Treatment with long-acting PTH compounds
아센디스 파마 본 디지즈 에이/에스 스프로괴 케넷
2024, KR-20240082355-A
LONG-ACTING PTH COMPOUND TREATMENTS
ASCENDIS PHARMA BONE DISEASES AS
2024, IL-311539-A
LONG-ACTING PTH COMPOUND TREATMENTS
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT
2024, AU-2022350937-A1
LONG-ACTING PTH COMPOUND TREATMENTS
ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT
2023, WO-2023046732-A1
LONG-ACTING PTH COMPOUND TREATMENTS
Ascendis Pharma Bone Diseases AS SPROGOE KENNETT
2023, CA-3230895-A1
